Hull Hans - Insider Non-Derivative Transactions at PLIANT THERAPEUTICS, INC. (PLRX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jul 10, 2024, Hull Hans's relationship to PLIANT THERAPEUTICS, INC. (PLRX) is Officer (Chief Business Officer), and currently has 227,494 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PLRX insiders.

Data Source: SEC.
Hull Hans - Insider Non-Derivative Transactions of PLRX Common Stock
Hull Hans - Insider Non-Derivative Transactions at PLRX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 11, 2024 Sell -- (Common Stock) 9900 11.56 227494
Jul 10, 2024 Acquisition -- (Common Stock) 19337 0 237394
Jan 24, 2024 Acquisition -- (Common Stock) 31500 0 216569
Jan 18, 2024 Sell -- (Common Stock) 9786 17.23 185069
Aug 5, 2023 Sell -- (Common Stock) 20050 20.01 194855
Aug 5, 2023 M -- (Common Stock) 8791 2.08 214905
Aug 4, 2023 Sell -- (Common Stock) 13069 20 206114
Aug 4, 2023 Sell -- (Common Stock) 1800 20 206114
Aug 4, 2023 M -- (Common Stock) 1800 2.08 207914
Jul 18, 2023 Sell -- (Common Stock) 17937 18.01 219183
Jul 15, 2023 Acquisition -- (Common Stock) 35156 0 237120
Mar 31, 2023 Sell -- (Common Stock) 9036 26.52 201964
Mar 30, 2023 Acquisition -- (Common Stock) 17578 0 211000
Jan 26, 2023 Acquisition -- (Common Stock) 54000 0 192191